Therapeutic target identification and corresponding drug development is a demanding task for the treatment of lung adeno-carcinoma, especially the most malignant proximal-proliferative subtype without druggable protein kinase mutations. Using a cell-SELEX-generated aptamer, we discovered a new tumor